Deutsche Bank’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $263K | Buy |
285,775
+29,924
| +12% | +$36.2K | ﹤0.01% | 2885 |
|
|
2025
Q4 | $327K | Buy |
255,851
+10,824
| +4% | +$14.5K | ﹤0.01% | 2784 |
|
|
2025
Q3 | $319K | Buy |
245,027
+27,776
| +13% | +$36.4K | ﹤0.01% | 2810 |
|
|
2025
Q2 | $261K | Sell |
217,251
-15,099
| -6% | -$16.7K | ﹤0.01% | 2818 |
|
|
2025
Q1 | $251K | Sell |
232,350
-25,891
| -10% | -$36.4K | ﹤0.01% | 2848 |
|
|
2024
Q4 | $452K | Buy |
258,241
+89,781
| +53% | +$167K | ﹤0.01% | 2662 |
|
|
2024
Q3 | $325K | Buy |
168,460
+42,668
| +34% | +$83.6K | ﹤0.01% | 2686 |
|
|
2024
Q2 | $223K | Buy |
125,792
+121,593
| +2,896% | +$297K | ﹤0.01% | 2745 |
|
|
2024
Q1 | $11.4K | Buy |
+4,199
| New | +$10.1K | ﹤0.01% | 3524 |
|
|
2022
Q2 | – | Sell |
-41,650
| Closed | -$149K | – | 4233 |
|
|
2022
Q1 | $149K | Sell |
41,650
-4,916
| -11% | -$17K | ﹤0.01% | 3414 |
|
|
2021
Q4 | $182K | Buy |
46,566
+2,449
| +6% | +$11.5K | ﹤0.01% | 3434 |
|
|
2021
Q3 | $291K | Sell |
44,117
-690
| -2% | -$4.54K | ﹤0.01% | 3355 |
|
|
2021
Q2 | $276K | Sell |
44,807
-2,885
| -6% | -$15.4K | ﹤0.01% | 3594 |
|
|
2021
Q1 | $215K | Sell |
47,692
-4,504
| -9% | -$24.7K | ﹤0.01% | 3597 |
|
|
2020
Q4 | $313K | Buy |
52,196
+8,899
| +21% | +$58.5K | ﹤0.01% | 3204 |
|
|
2020
Q3 | $322K | Sell |
43,297
-124,030
| -74% | -$856K | ﹤0.01% | 2923 |
|
|
2020
Q2 | $671K | Buy |
167,327
+114,988
| +220% | +$400K | ﹤0.01% | 2473 |
|
|
2020
Q1 | $133K | Sell |
52,339
-69,504
| -57% | -$228K | ﹤0.01% | 3136 |
|
|
2019
Q4 | $422K | Buy |
121,843
+19,833
| +19% | +$69.8K | ﹤0.01% | 2811 |
|
|
2019
Q3 | $471K | Sell |
102,010
-259,259
| -72% | -$2.04M | ﹤0.01% | 2704 |
|
|
2019
Q2 | $4.45M | Sell |
361,269
-838,854
| -70% | -$10.7M | ﹤0.01% | 1891 |
|
|
2019
Q1 | $15.9M | Buy |
1,200,123
+1,026,860
| +593% | +$10.8M | 0.01% | 1100 |
|
|
2018
Q4 | $1.49M | Buy |
173,263
+45,630
| +36% | +$355K | ﹤0.01% | 2603 |
|
|
2018
Q3 | $956K | Buy |
127,633
+11,016
| +9% | +$78.3K | ﹤0.01% | 3364 |
|
|
2018
Q2 | $695K | Buy |
116,617
+12,858
| +12% | +$73.3K | ﹤0.01% | 3657 |
|
|
2018
Q1 | $604K | Sell |
103,759
-34,942
| -25% | -$229K | ﹤0.01% | 3603 |
|
|
2017
Q4 | $816K | Buy |
138,701
+25,074
| +22% | +$137K | ﹤0.01% | 3334 |
|
|
2017
Q3 | $571K | Sell |
113,627
-1,669
| -1% | -$7.02K | ﹤0.01% | 3354 |
|
|
2017
Q2 | $464K | Buy |
115,296
+7,708
| +7% | +$36.5K | ﹤0.01% | 3488 |
|
|
2017
Q1 | $611K | Sell |
107,588
-11,776
| -10% | -$74.6K | ﹤0.01% | 2969 |
|
|
2016
Q4 | $867K | Buy |
119,364
+41,080
| +52% | +$258K | ﹤0.01% | 2804 |
|
|
2016
Q3 | $625K | Sell |
78,284
-199,690
| -72% | -$1.83M | ﹤0.01% | 3090 |
|
|
2016
Q2 | $2.51M | Buy |
277,974
+118,976
| +75% | +$1.12M | ﹤0.01% | 2247 |
|
|
2016
Q1 | $1.28M | Sell |
158,998
-105,808
| -40% | -$763K | ﹤0.01% | 2654 |
|
|
2015
Q4 | $2.86M | Sell |
264,806
-86,282
| -25% | -$847K | ﹤0.01% | 2180 |
|
|
2015
Q3 | $2.85M | Buy |
351,088
+98,401
| +39% | +$1.55M | ﹤0.01% | 2227 |
|
|
2015
Q2 | $6.11M | Sell |
252,687
-8,099
| -3% | -$256K | ﹤0.01% | 1665 |
|
|
2015
Q1 | $11M | Buy |
260,786
+80,501
| +45% | +$3.18M | 0.01% | 1265 |
|
|
2014
Q4 | $6.08M | Buy |
180,285
+144,948
| +410% | +$4.1M | ﹤0.01% | 1797 |
|
|
2014
Q3 | $864K | Sell |
35,337
-2,364
| -6% | -$66.5K | ﹤0.01% | 3134 |
|
|
2014
Q2 | $1.11M | Sell |
37,701
-22,593
| -37% | -$724K | ﹤0.01% | 2867 |
|
|
2014
Q1 | $2.65M | Buy |
60,294
+18,980
| +46% | +$835K | ﹤0.01% | 2220 |
|
|
2013
Q4 | $1.58M | Sell |
41,314
-24,456
| -37% | -$720K | ﹤0.01% | 2400 |
|
|
2013
Q3 | $1.44M | Sell |
65,770
-73,563
| -53% | -$1.45M | ﹤0.01% | 2694 |
|
|
2013
Q2 | $2.43M | Buy |
+139,333
| New | +$2.45M | ﹤0.01% | 2094 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Deutsche Bank's LAB Position: Q1 2026 in Review
Deutsche Bank increased its Standard BioTools (LAB) stake by 12% in Q1 2026, buying an estimated $36.2K and bringing the position to 285,775 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #2885.
Deutsche Bank first reported a position in LAB in Q2 2013 and has held it in 45 quarters since. The position peaked at $15.9M in Q1 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Deutsche Bank held 285,775 shares of Standard BioTools worth $263K as of Q1 2026.
- Deutsche Bank bought 29,924 Standard BioTools shares in Q1 2026, an estimated $36.2K.
- Standard BioTools made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2885 holding.
- Deutsche Bank first reported a position in Standard BioTools in Q2 2013 and has held it in 45 quarters since.
- Deutsche Bank's Standard BioTools position peaked at $15.9M in Q1 2019.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.